Sonoma Pharmaceuticals (SNOA) Research & Development (2020 - 2022)
Sonoma Pharmaceuticals (SNOA) has 3 years of Research & Development data on record, last reported at $509000.0 in Q4 2012.
- For Q4 2012, Research & Development changed 0.0% year-over-year to $509000.0; the TTM value through Dec 2012 reached $2.0 million, down 4.92%, while the annual FY2012 figure was $2.0 million, 3.18% down from the prior year.
- Research & Development reached $509000.0 in Q4 2012 per SNOA's latest filing, down from $513000.0 in the prior quarter.
- Across five years, Research & Development topped out at $630000.0 in Q1 2011 and bottomed at $396000.0 in Q2 2010.
- Average Research & Development over 3 years is $507363.6, with a median of $509000.0 recorded in 2011.
- The widest YoY moves for Research & Development: up 22.02% in 2012, down 24.44% in 2012.
- A 3-year view of Research & Development shows it stood at $467000.0 in 2010, then grew by 8.99% to $509000.0 in 2011, then changed by 0.0% to $509000.0 in 2012.
- Per Business Quant database, its latest 3 readings for Research & Development were $509000.0 in Q4 2012, $513000.0 in Q3 2012, and $532000.0 in Q2 2012.